ATE346036T1 - Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen - Google Patents

Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen

Info

Publication number
ATE346036T1
ATE346036T1 AT99924434T AT99924434T ATE346036T1 AT E346036 T1 ATE346036 T1 AT E346036T1 AT 99924434 T AT99924434 T AT 99924434T AT 99924434 T AT99924434 T AT 99924434T AT E346036 T1 ATE346036 T1 AT E346036T1
Authority
AT
Austria
Prior art keywords
arthritis
cancer
treatment
retinal diseases
antiangiogenic
Prior art date
Application number
AT99924434T
Other languages
English (en)
Inventor
Megumi Kawai
Jack Henkin
George S Sheppard
Richard A Craig
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE346036T1 publication Critical patent/ATE346036T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99924434T 1998-05-22 1999-05-21 Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen ATE346036T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8406398A 1998-05-22 1998-05-22

Publications (1)

Publication Number Publication Date
ATE346036T1 true ATE346036T1 (de) 2006-12-15

Family

ID=22182661

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99924434T ATE346036T1 (de) 1998-05-22 1999-05-21 Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen

Country Status (10)

Country Link
EP (1) EP1080070B1 (de)
JP (1) JP4554816B2 (de)
AT (1) ATE346036T1 (de)
CA (1) CA2332535C (de)
CY (1) CY1105977T1 (de)
DE (1) DE69934113T2 (de)
DK (1) DK1080070T3 (de)
ES (1) ES2276519T3 (de)
PT (1) PT1080070E (de)
WO (1) WO1999061406A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632961B1 (en) 1998-05-22 2003-10-14 Abbott Laboratories Antiangiogenic drug to treat cancer, arthritis and retinopathy
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
CA2470214A1 (en) * 2001-12-13 2003-06-26 Abbott Laboratories 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer
US7592466B2 (en) 2003-10-09 2009-09-22 Abbott Laboratories Ureas having antiangiogenic activity
DE602004018811D1 (de) * 2003-10-09 2009-02-12 Abbott Lab Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
JP5221146B2 (ja) 2005-01-13 2013-06-26 ユニバーシティ・オブ・ウーロンゴン ペプチド化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1922205A (en) * 1932-01-26 1933-08-15 Squibb & Sons Inc 2-carboxy-5-amino diphenyl
GB1498996A (en) * 1975-10-09 1978-01-25 Hidaka H Omega-aminoalkanoic acid arylamides
IT1050750B (it) * 1975-12-05 1981-03-20 Erba Carlo Spa Derivati della 3.4 di idro chinazolina
US4147802A (en) * 1978-03-17 1979-04-03 Stanley Drug Products, Inc. Method of treating bacterial infections
EP0183271B1 (de) * 1984-11-30 1990-05-16 Shosuke Okamoto Lysinderivat und Proteinase-Inhibitor
US5238652A (en) * 1990-06-20 1993-08-24 Drug Screening Systems, Inc. Analytical test devices for competition assay for drugs of non-protein antigens using immunochromatographic techniques
GB9200415D0 (en) * 1992-01-09 1992-02-26 Bagshawe Kenneth D Inactivation of cytotoxic drugs
ZA935617B (en) * 1992-08-14 1994-03-07 Akzo Nv Antiprogestogen containing contraceptives.

Also Published As

Publication number Publication date
JP4554816B2 (ja) 2010-09-29
CA2332535A1 (en) 1999-12-02
PT1080070E (pt) 2007-02-28
DE69934113D1 (de) 2007-01-04
DE69934113T2 (de) 2007-06-06
WO1999061406A3 (en) 2000-01-27
CA2332535C (en) 2006-02-28
EP1080070A2 (de) 2001-03-07
JP2002516303A (ja) 2002-06-04
DK1080070T3 (da) 2007-02-26
EP1080070B1 (de) 2006-11-22
ES2276519T3 (es) 2007-06-16
CY1105977T1 (el) 2011-04-06
WO1999061406A2 (en) 1999-12-02

Similar Documents

Publication Publication Date Title
NO20003018L (no) Triazinangiogenese-inhibitorer
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
MY138252A (en) Azabicyclic-substitud fused-heteroaryl compounds for the treatment of disease
MXPA05002420A (es) Compuestos de tiazol para el tratamiento de trastornos neurodegenerativos.
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
BR0015911A (pt) Derivados de benzoimidazole úteis como agentes antiproliferativos
DE602004030222D1 (de) 2-oxo-1,3,5-perhydrotriazapinderivate, die sich zur behandlung von hyperproliferativen, angiogenen und entzündlichen erkrankungen eignen
MXPA05012196A (es) Compuestos de isoxazol e isotiazol para el tratamiento de trastornos neurodegenerativos.
DE69933885D1 (de) Triphenylbutenderivate zur behandlung von neurologischen störungen
ATE346036T1 (de) Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen
MY136718A (en) Sulfonamide compounds for the treatment of neurodegenerative disorders
TW200510351A (en) Oxazole compounds for the treatment of neurodegenerative disorders
MXPA04000805A (es) Peptidos que tienen actividad antiangiogenica.
ATE402150T1 (de) Pyrazolaminverbindungen zur behandlung neurodegenerativer erkrankungen
ATE399758T1 (de) Derivate von 1-phenylalkancarbonsäuren zur behandlung von neurodegenerativen krankheiten
NO20032411D0 (no) Anvendelse av substituerte 6-dimetylaminometyl-1-fenyl- cykloheksan-forbindelser for behandling av urininkontinens
DK1212315T3 (da) Nye chalconer
DE60219680D1 (de) Amin-1,2- und -1,3-diolverbindungen und deren verwendung zur behandlung von alzheimer-krankheit
PT1077694E (pt) Produtos terapeuticos de arilnitrona para o tratamento da doenca inflamatoria dointestino
TW200730177A (en) 4 anilino-3-quinolinecarbonitriles for the treatment of cancer
ATE263556T1 (de) Phenylessigsäure enthaltende zusammensetzungen zur behandlung und vorbeugung der atherosklerose und der restenose
ATE327240T1 (de) 2ß OXO-VORUSCHARIN UND DERIVATEN
EA200500382A1 (ru) Соединения тиазола для лечения нейродегенеративных расстройств

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1080070

Country of ref document: EP